Growth Factors of Influenza Medication Market
The Influenza Medication Market size was valued at USD 889.2 million in 2018 and is projected treach USD 1,167.9 million by 2032, exhibiting a CAGR of 2.4% during the forecast period of 2024-2032.
The COVID-19 pandemic considerably impacted the influenza remedy marketplace by means of moving healthcare priorities and sources toward managing COVID-19 instances. Public health measures like huge masks utilization, social distancing, and increased hygiene attention added approximately a wonderful decline in influenza times globally, lowering the call for for influenza medicinal drugs. However, the overlap of signs and symptoms between COVID-19 and influenza heightened the point of interest on differentiating analysis and remedy, spurring investments in antiviral studies. The pandemic additionally underscored the importance of preparedness for breathing illnesses, using governments and healthcare agencies treinforce stockpiles of influenza medicines for destiny outbreaks.
A key fashion in the influenza remedy marketplace is the improvement of next-generation antiviral remedy alternatives and combination capsules. Advances in biotechnology have brought about a surge in novel influenza treatments that focus on the virus more correctly and reduce resistance risks. Combination remedies, which encompass antivirals paired with immunomodulators, are gaining traction for his or her capacity tbeautify affected person consequences. Additionally, virtual health gadget collectively with telemedicine are streamlining influenza prognosis and medicine delivery, at the same time as pharmaceutical corporations are integrating artificial intelligence tenhance up drug discovery processes, setting new benchmarks in treatment efficacy and affected individual care.
One essential using detail in the influenza medicine marketplace is the developing global occurrence of seasonal influenza and the growing recognition of its headaches. With tens of tens of tens of millions affected yearly, the growing burden on healthcare systems has fueled name for for effective and on hand antiviral remedies. Government initiatives selling vaccination and early remedy have amplified the focal point on preventive and healing measures.
Comprehensive Analysis of Influenza Medication Market
The Influenza Medication Market growth is rising at an exponential rate due tits marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated By treatment, by influenza, by route of administration, by distribution channel. By Treatment include Baloxavir marboxil, Oseltamivir phosphate, Others. By Influenza Type include Influenza A, Influenza B. By Route of Administration include Oral, Others. By Distribution Channel include Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ,Others.
The North America region lead the Influenza Medication Market share by benefitting a market size of USD 527.3 million High prevalence of the several forms of influenza in the region, coupled with the new and anticipated product launches, will drive the market growth in the region.
The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, EksBionics, Vuzix,these market players provide a level-playing competitive landscape.
October 2019: Genentech, Inc. announced the FDA approval of Xofluza (Baloxavir Marboxil) for individuals at an elevated risk of developing influenza-related complications.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2015-2026
Base Year 2018
Forecast Period 2019-2026
Historical Period 2015-2017
Unit Value (USD million)
Segmentation By Treatment
Baloxavir marboxil
Oseltamivir phosphate
Others
By Influenza Type
Influenza A
Influenza B
By Route of Administration
Oral
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Geography
North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Overview of Influenza Epidemiology
- 4.2. Analysis of Disease Burden of Influenza, By Key Regions
- 4.3. New Product Launches
- 4.4. Pipeline Analysis
- 4.5. Analysis of the Impact of the Launch of Generics on the Influenza Medication Market
- 4.6. Key Industry Developments
- 5. Global Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Treatment
- 5.2.1. Baloxavir marboxil
- 5.2.2. Oseltamivir phosphate
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast – By Influenza Type
- 5.3.1. Influenza A
- 5.3.2. Influenza B
- 5.4. Market Analysis, Insights and Forecast – By Route of Administration
- 5.4.1. Oral
- 5.4.2. Others
- 5.5. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.5.1. Hospital Pharmacies
- 5.5.2. Retail Pharmacies
- 5.5.3. Online Pharmacies
- 5.5.4. Others
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
- 6. North America Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Treatment
- 6.2.1. Baloxavir marboxil
- 6.2.2. Oseltamivir phosphate
- 6.2.3. Others
- 6.3. Market Analysis – By Influenza Type
- 6.3.1. Influenza A
- 6.3.2. Influenza B
- 6.4. Market Analysis – By Route of Administration
- 6.4.1. Oral
- 6.4.2. Others
- 6.5. Market Analysis – By Distribution Channel
- 6.5.1. Hospital Pharmacies
- 6.5.2. Retail Pharmacies
- 6.5.3. Online Pharmacies
- 6.5.4. Others
- 6.6. Market Analysis – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
- 7. Europe Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Treatment
- 7.2.1. Baloxavir marboxil
- 7.2.2. Oseltamivir phosphate
- 7.2.3. Others
- 7.3. Market Analysis – By Influenza Type
- 7.3.1. Influenza A
- 7.3.2. Influenza B
- 7.4. Market Analysis – By Route of Administration
- 7.4.1. Oral
- 7.4.2. Others
- 7.5. Market Analysis – By Distribution Channel
- 7.5.1. Hospital Pharmacies
- 7.5.2. Retail Pharmacies
- 7.5.3. Online Pharmacies
- 7.5.4. Others
- 7.6. Market Analysis – By Country/Sub-Region
- 7.6.1. U.K.
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Spain
- 7.6.5. Italy
- 7.6.6. Scandinavia
- 7.6.7. Rest of Europe
- 8. Asia Pacific Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Treatment
- 8.2.1. Baloxavir marboxil
- 8.2.2. Oseltamivir phosphate
- 8.2.3. Others
- 8.3. Market Analysis – By Influenza Type
- 8.3.1. Influenza A
- 8.3.2. Influenza B
- 8.4. Market Analysis – By Route of Administration
- 8.4.1. Oral
- 8.4.2. Others
- 8.5. Market Analysis – By Distribution Channel
- 8.5.1. Hospital Pharmacies
- 8.5.2. Retail Pharmacies
- 8.5.3. Online Pharmacies
- 8.5.4. Others
- 8.6. Market Analysis – By Country/Sub-Region
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. Southeast Asia
- 8.6.6. Rest of Asia Pacific
- 9. Latin America Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Treatment
- 9.2.1. Baloxavir marboxil
- 9.2.2. Oseltamivir phosphate
- 9.2.3. Others
- 9.3. Market Analysis – By Influenza Type
- 9.3.1. Influenza A
- 9.3.2. Influenza B
- 9.4. Market Analysis – By Route of Administration
- 9.4.1. Oral
- 9.4.2. Others
- 9.5. Market Analysis – By Distribution Channel
- 9.5.1. Hospital Pharmacies
- 9.5.2. Retail Pharmacies
- 9.5.3. Online Pharmacies
- 9.5.4. Others
- 9.6. Market Analysis – By Country/Sub-Region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
- 10. Middle East & Africa Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Treatment
- 10.2.1. Baloxavir marboxil
- 10.2.2. Oseltamivir phosphate
- 10.2.3. Others
- 10.3. Market Analysis – By Influenza Type
- 10.3.1. Influenza A
- 10.3.2. Influenza B
- 10.4. Market Analysis – By Route of Administration
- 10.4.1. Oral
- 10.4.2. Others
- 10.5. Market Analysis – By Distribution Channel
- 10.5.1. Hospital Pharmacies
- 10.5.2. Retail Pharmacies
- 10.5.3. Online Pharmacies
- 10.5.4. Others
- 10.6. Market Analysis – By Country/ Sub-Region
- 10.6.1. GCC Countries
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles
- 11.5.1. Genentech, Inc.
- 11.5.1.1. Overview,
- 11.5.1.2. Products & Services,
- 11.5.1.3. SWOT Analysis,
- 11.5.1.4. Recent Developments,
- 11.5.1.5. Strategies,
- 11.5.1.6. Financials (Based On Availability)
- 11.5.2. Shionogi & Co., Ltd.
- 11.5.2.1. Overview,
- 11.5.2.2. Products & Services,
- 11.5.2.3. SWOT Analysis,
- 11.5.2.4. Recent Developments,
- 11.5.2.5. Strategies,
- 11.5.2.6. Financials (Based On Availability)
- 11.5.3. Seqirus (CSL)
- 11.5.3.1. Overview,
- 11.5.3.2. Products & Services,
- 11.5.3.3. SWOT Analysis,
- 11.5.3.4. Recent Developments,
- 11.5.3.5. Strategies,
- 11.5.3.6. Financials (Based On Availability)
- 11.5.4. BIOCRYST PHARMACEUTICALS, INC.
- 11.5.4.1. Overview,
- 11.5.4.2. Products & Services,
- 11.5.4.3. SWOT Analysis,
- 11.5.4.4. Recent Developments,
- 11.5.4.5. Strategies,
- 11.5.4.6. Financials (Based On Availability)
- 11.5.5. GlaxoSmithKline plc
- 11.5.5.1. Overview,
- 11.5.5.2. Products & Services,
- 11.5.5.3. SWOT Analysis,
- 11.5.5.4. Recent Developments,
- 11.5.5.5. Strategies,
- 11.5.5.6. Financials (Based On Availability)
- 11.5.6. Lupin Limited
- 11.5.6.1. Overview,
- 11.5.6.2. Products & Services,
- 11.5.6.3. SWOT Analysis,
- 11.5.6.4. Recent Developments,
- 11.5.6.5. Strategies,
- 11.5.6.6. Financials (Based On Availability)
- 11.5.7. Teva Pharmaceutical Industries Ltd.
- 11.5.7.1. Overview,
- 11.5.7.2. Products & Services,
- 11.5.7.3. SWOT Analysis,
- 11.5.7.4. Recent Developments,
- 11.5.7.5. Strategies,
- 11.5.7.6. Financials (Based On Availability)
- 11.5.8. Zydus Pharmaceuticals, Inc. (Zydus Cadila)
- 11.5.8.1. Overview,
- 11.5.8.2. Products & Services,
- 11.5.8.3. SWOT Analysis,
- 11.5.8.4. Recent Developments,
- 11.5.8.5. Strategies,
- 11.5.8.6. Financials (Based On Availability)
- 11.5.9. Amneal Pharmaceuticals LLC
- 11.5.9.1. Overview,
- 11.5.9.2. Products & Services,
- 11.5.9.3. SWOT Analysis,
- 11.5.9.4. Recent Developments,
- 11.5.9.5. Strategies,
- 11.5.9.6. Financials (Based On Availability)
- 11.5.10. Macleods Pharmaceuticals Ltd.
- 11.5.10.1. Overview,
- 11.5.10.2. Products & Services,
- 11.5.10.3. SWOT Analysis,
- 11.5.10.4. Recent Developments,
- 11.5.10.5. Strategies,
- 11.5.10.6. Financials (Based On Availability)
- 11.5.11. Alvogen
- 11.5.11.1. Overview,
- 11.5.11.2. Products & Services,
- 11.5.11.3. SWOT Analysis,
- 11.5.11.4. Recent Developments,
- 11.5.11.5. Strategies,
- 11.5.11.6. Financials (Based On Availability)
- 11.5.12. Others
- 11.5.12.1. Overview,
- 11.5.12.2. Products & Services,
- 11.5.12.3. SWOT Analysis,
- 11.5.12.4. Recent Developments,
- 11.5.12.5. Strategies,
- 11.5.12.6. Financials (Based On Availability)
- 12. Strategic Recommendations "
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook